1. Ahmad, N. S., Islahudin, F., & Paraidathathu, T. (2014). Factors associated with good glycemic control among patients with type 2 diabetes mellitus. Journal of Diabetes Investigation, 5(5), 563–569. http://doi.org/10.1111/jdi.12175
2. García-Pérez, L.-E., Álvarez, M., Dilla, T., Gil-Guillén, V., & Orozco-Beltrán, D. (2013). Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes Therapy, 4(2), 175–194. http://doi.org/10.1007/s13300-013-0034-y
3. Khoury, C. C., Chen, S., & Ziyadeh, F. N. (2015). Pathophysiology of Diabetic Nephropathy. In Chronic Renal Disease (pp. 151-162).
4. Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565-4592.
5. Pistrosch, F., Natali, A., & Hanefeld, M. (2011). Is hyperglycemia a cardiovascular risk factor?. Diabetes Care, 34(Supplement 2), S128-S131.
6. Rosenfield, R. L., & Ehrmann, D. A. (2016). The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine reviews, 37(5), 467-520.

The download will start shortly.